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Johne’s Disease or Paratuberculosis is a chronic granulomatous enteritis disease affecting ruminants. Detection of subclinically
infected animals is difficult, hampering the control of this disease. The aim of this work was to evaluate the performance of
detection of IgG isotypes in a PPA-ELISA to improve the recognition of cattle naturally infected with Map in different stages.
A total of 108 animals from Tuberculosis-free herds were grouped as follows: exposed (n = 30), subclinically infected (n = 26),
clinically infected (n = 14), and healthy controls (n = 38). Receiver-operating characteristic (ROC) curves of isotypes/PPA-ELISAs
were constructed and areas under the curves were compared to evaluate the performance of each test. Our study demonstrated
that the conventional PPA-ELISA (detecting IgG) is the best to identify clinically infected animals with high sensitivity (92.9%)
and specificity (100%). Meanwhile, IgG2/PPA-ELISA improved the number of subclinically infected cattle detected as compared
with conventional IgG/PPA-ELISA (53.8 versus 23.1%). In addition, it had the maximum sensitivity (65.0%, taking into account
all Map-infected cattle). In conclusion, the combination of IgG and IgG2/PPA-ELISAs may improve the identification of Map-
infected cattle in different stages of disease. The usefulness of IgG2 detection in serological tests for Johne’s Disease diagnosis
should be further evaluated.
1. Introduction
Johne’s Disease (JD) or Paratuberculosis is a chronic gran-
ulomatous enteritis disease affecting ruminants [1, 2]. It
is caused by Mycobacterium avium subsp. paratuberculosis
(Map) and leads to major economic losses in the dairy indus-
try worldwide [3]. Map has been implicated as a possible
cause of Crohn’s disease, which is a chronic granulomatous
ileocolitis in humans. However, its role in this pathology
remains controversial [4–6].
Calves are the most susceptible category during the first
months of life and become infected through ingestion of
Map-contaminated colostrum, milk, or feces [2, 7]. Fetal
transmission is also possible when dams are infected with
Map [7, 8].
During initial infection, the immune response is pre-
dominated by a cell-mediated immune profile (Th1). Sub-
clinically infected animals are generally low Map fecal
shedders and have undetectable levels of Map-specific serum
antibodies and increasing specific gamma interferon (IFN-γ)
responses [9]. After a long incubation period (years), a pro-
portion of infected animals develop to a clinical stage, which
is characterized by chronic diarrhea, protein-losing enterop-
athy, cachexia, and eventual death. In addition, increases in
bacterial shedding in feces and serum antibody titers have
been described in this stage of JD, suggesting a shift of the
immune response to a humoral profile (Th2) [1, 10, 11]. The
humoral immune response against mycobacterial infections
has been considered nonprotective [1, 2]. However, it has
been demonstrated that antibodies have an active role in
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Map infection in vitro. Map immune sera or purified specific
antibodies enhance bacterial interaction with macrophages,
improve the activation of the nuclear factor NF-kB in
infected cells, and affect Map intracellular viability [12–14].
The control of JD has been difficult for several reasons.
Fecal culture on conventional solid media is expensive, labo-
rious and slow (requiring 6 months for assay ending), and
has low sensitivity [15–17]. Detection of cellular immune
response by either the skin test or IFN-γ production is useful
for early diagnosis of infection, but these assays have high
variability and low specificity [18, 19]. Vaccines have been
demonstrated to decrease the amount of Map shedding,
to prevent the development of the clinical stage and to
reduce the impact on milk production. However, they do not
prevent infection and shedding of the bacteria and interfere
with Tuberculosis and JD diagnosis [20].
Although conventional ELISA (detecting IgG) has low
sensitivity during the subclinical stage of the infection, it is
the test most used for JD control due to its low-cost, high-
throughput, standardized protocols, and correlation with
Map fecal shedding levels [21–23]. Various antigens of Map
have been studied, including protoplasmic antigen (PPA),
lipoarabinomannan (LAM), p34 protein carboxy-terminal
(P34-cx), purified protein derivative (PPDp), and heat shock
proteins (Hsp), of which PPA is the one most used for dia-
gnosis [21–23]. Production of Map-specific isotypes switches
during the course of the disease [10, 24, 25] with Th1
responses being related to IgM and IgG2, and Th2 responses
being related to IgG1 and IgA in cattle [26]. In the same way,
high levels of specific IgG1 against several antigens have been
detected in sera from Map-infected cattle at a clinical stage
of the disease [13, 14, 24, 25]. In a previous study, we have
shown increases in the levels of Map-specific IgG2 in cattle at
both the subclinical and clinical stages of JD [25].
The aim of this work was to evaluate the performance
of detection of IgG isotypes in a PPA-ELISA to improve the
recognition of cattle naturally infected with Map in different
stages of the disease.
2. Materials and Methods
2.1. Animals. Sera from 108 Holstein-Frisian bovines from
Tuberculosis-free accredited dairy herds from the Pampas
region of Argentina were used to assess the performance of
IgG, IgG1, and IgG2/PPA-ELISAs.
JD diagnosis was achieved as previously described [25].
Briefly, we examined animals for clinical signs of disease
and for Map presence in milk and fecal-isolated colonies
by PCR identification of the IS900 fragment. Milk samples
were concentrated by Map-specific immunomagnetic beads
(NEB, New England Biolabs, Ipswich, MA, USA) [27, 28].
Fecal cultures were carried out in Herrold egg yolk medium
with mycobactin J (Allied Monitor Inc., Fayette, MO, USA)
and pyruvate (Sigma-Aldrich Corp., St. Louis, MO, USA).
Animals were grouped as follows:
(i) exposed (E, n = 30): from Map-infected herds, with-
out clinical signs of JD and negative to IS900-PCR
(from feces and milk);
(ii) subclinically infected (SC, n = 26): from Map-infect-
ed herds, without clinical signs of JD and positive to
IS900-PCR (from feces, milk, or both);
(iii) clinically infected (C, n = 14): from Map-infected
herds with chronic diarrhea and positive to IS900-
PCR (from feces, milk, or both);
(iv) healthy control (Hc, n = 38): from Map-free herds
and negative to IS900-PCR (from feces and milk).
2.2. ELISAs. IgG, IgG1, and IgG2/PPA-ELISAs were eval-
uated using sera from the 108 bovines. Cross-reactive
antibodies were preadsorbed with Mycobacterium phlei [29],
which had been grown at 37◦C in Middlebrook 7H9 broth
(DifcoTM, BD biosciences, Franklin Lakes, NJ, and USA)
containing 10% albumin-dextrose-sodium chloride and then
heat-inactivated at 85◦C for 30 minutes. For preadsorp-
tion, sera diluted 1:5 with PBS containing heat-inactivated
Mycobacterium phlei (optical density (OD) at 600 nm of 1)
were incubated at 37◦C for 1 h with shaking, and then at 4◦C
for 16 h.
Flat-bottomed 96-well polystyrene plates were coated
(4◦C, 16 h) with 2 μg/well of PPA (Allied Monitor Inc.) in
50 μL of 0.05 M sodium carbonate buffer pH 9.6. The plates
were washed three times with rinsing buffer (0.05% Tween
20 in PBS) and blocked with 10% skimmed milk in PBS. All
subsequent incubations were performed at 37◦C for 1 h and
after each incubation, plates were washed three times with
rinsing buffer. A volume of 50 μL of preadsorbed sera at a
final dilution of 1:5 (for IgG2 analyses) or 1:100 (for IgG
and IgG1 analyses) in 5% skimmed milk in PBS was added.
The antibodies used were: HRP-conjugated goat anti-bovine
IgG (KPL, Kirkegaard & Perry Laboratories Inc., Gaithsburg,
MD, USA), HRP-conjugated sheep anti-bovine IgG1 (Bethyl
Laboratories Inc., Montgomery, TX, USA), and mouse
monoclonal anti-bovine IgG2 (Sigma-Aldrich Co.) followed
by HRP-conjugated goat anti-mouse IgG (KPL). Plates were
developed using ortho-phenylendiamine dihydrochloride
(OPD, Sigma-Aldrich Co.) in citrate buffer (Sigma-Aldrich
Co.) and read in an OpsysMR spectrophotometer (Dynex
Technologies, Chantilly, VA, USA). Results are expressed as
mean OD values at 490 nm.
2.3. Data Analysis. All experiments were conducted in
duplicate or triplicate and repeated at least twice.
STATISTIX 8.0 (Analytical software, Tallahassee, USA)
was used to analyze data of the humoral immune response
against PPA. The logarithms of the mean OD values obtained
were compared between groups. The levels of IgG and IgG2
were studied with ANOVA followed by Tukey’s test, whereas
those of IgG1 were analyzed with the Kruskal-Wallis test
followed by pairwise comparisons.
CurvMedCalc Software version 12 (Mariakerke, Bel-
gium) was used to evaluate the power of the IgG, IgG1,
and IgG2/PPA-ELISAs and to build the Receiver-operating
characteristic (ROC) curves of infected cattle. The sensi-
tivity of each test was estimated as % of infected cattle
(subclinically infected, clinically infected, or both) testing
positive at the cut-off chosen. The specificity of each test
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Figure 1: Results of isotypes/PPA-ELISAs. Dotplots of IgG (a), IgG1 (b), and IgG2 (c) PPA-ELISAs. Antibody responses are plotted as mean
optical density (OD); lines and numbers (over lines) represent cut-off points. Letters indicate a significant difference (P < 0.05) between
groups. Groups: healthy controls (Hc, n = 38), exposed (E, n = 30), subclinically infected (SC, n = 26), and clinically infected (C, n = 14).
was calculated as % of cattle from the healthy control group
testing negative at the cut-off chosen. ROC curves for IgG,
IgG1 and IgG2/PPA-ELISAs of subclinically and clinically
infected cattle were constructed as plots of sensitivity versus
100 minus specificity for each possible cut-off [30, 31].
Different methods were applied to assess the cut-off points
of each ELISA. The mean OD values of healthy control
group±2 standard deviation and the ROC curves of infected
cattle were analyzed. Cut-off points were selected from the
ROC curves in order to obtain the highest sensitivity for
subclinically infected cattle with a specificity of at least
90%. The area under each ROC curve (AUC) was estimated
and AUCs were compared using the method described by
DeLong et al [32].
The level of significance was set at a P value < 0.05.
3. Results
Results of the isotypes/PPA-ELISAs in sera from healthy con-
trol, exposed, subclinically infected, and clinically infected
cattle are shown in Figure 1 and Table 1. PPA-specific IgG
was significantly increased in sera from all groups of Map-
infected herds (exposed, subclinically infected, and clinically
infected) compared with the healthy control group. In
addition, the clinically infected group showed the highest
values detected. When the groups were evaluated by the
IgG1/PPA-ELISA, only the clinically infected group showed
high levels of this isotype. Meanwhile, the levels of specific
IgG2 were significantly increased in all groups from Map-
infected herds (P < 0.05).
The ROC curves of the IgG, IgG1, and IgG2/PPA-ELISAs
for the subclinically and clinically infected groups are shown
in Figure 2. As expected, the AUCs were higher for the
clinically infected group than for the subclinically infected
one (Table 2).
The IgG/PPA-ELISA showed the highest specificity
(100%) and sensitivity for clinically infected cattle (92.9%,
Table 3). However, this test detected as positive only 6/26 of
the subclinically infected animals and 8/30 of the exposed
animals (Table 1).
The IgG1/PPA-ELISA demonstrated low performance
and low sensitivity (27.5% of Map-infected cattle (subclin-
ically and clinically infected), Figure 2, Tables 2 and 3).
The IgG2/PPA-ELISA showed 92.1% of specificity and
the best performance for the subclinically infected group
(AUC = 0.812) as compared with the IgG/PPA-ELISA (AUC









































Figure 2: Performances of isotypes/PPA-ELISAs for subclinically infected (a) and clinically infected cattle (b). Receiver-operating
characteristic (ROC) curves for IgG, IgG1, and IgG2/PPA-ELISAs.
Table 1: Percentages of positivity of isotypes/PPA-ELISAs.
Groups IgG/PPA-ELISA IgG1/PPA-ELISA IgG2/PPA-ELISA
Hc 0.0% (0/38) 5.3% (2/38) 7.9% (3/38)
E 26.7% (8/30) 3.3% (1/30) 63.3% (19/30)
SC 23.1% (6/26) 11.5% (3/26) 53.8% (14/26)
C 92.9% (13/14) 57.1% (8/14) 85.7% (12/14)
Numbers of positive animals are shown between brackets. Groups: healthy
controls (Hc, n = 38), exposed (E, n = 30), subclinically infected (SC, n =
26), and clinically infected (C, n = 14).
= 0.719) and IgG1/PPA-ELISA (AUC = 0.526), detecting
53.8% of the subclinically infected animals and 63.3% of
the exposed animals (Figure 2 and Tables 1–3). In addition,
the IgG2/PPA-ELISA had the maximum sensitivity (65.0%,
taking into account all Map-infected cattle) and was able to
detect 26/40 of Map-infected cattle. In contrast, only 19/40
were identified by the IgG/PPA-ELISA.
4. Discussion
The response of isotypes in Map-infected cattle has been
previously studied [10, 13, 14, 24, 25]. We have described
Map-specific isotypes detecting high levels of IgG2 in sera
from Map-infected cattle at both the subclinical and clinical
stages of the disease [13, 25]. Taking into account that PPA is
the Map antigen most widely used [13, 22, 33], in the present
work, we developed isotypes/PPA-ELISAs to evaluate their
application in diagnosis of JD in cattle.
It has been described that Map-infected animals in the
clinical stage are high shedders of bacteria in feces, and thus
have the greatest potential to transmit Map to other animals
of the herd [7, 34]. Meanwhile, subclinically infected cattle
usually shed lower levels of Map and they are the largest part
of the Map-infected herds, so detection of these animals is
considered of great importance for JD control [35].
In this work, we detected an increase in the level of PPA-
specific IgG in sera from clinically infected animals. Similar
responses against other Map antigens have been previously
reported [10, 13, 25]. We also detected increases in the levels
of specific IgG in the subclinically infected group, in contrast
to our previous study using Map-whole bacteria as antigen
[25]. The IgG/PPA-ELISA demonstrated a perfect specificity
(100%); this is in accordance with published studies that have
described specificities from 94 to 100% [21, 36].
Although specific IgG1 against Map-antigens has been
described as characteristic of clinically infected animals [13,
14, 24, 25], in the present study the detection of PPA-specific
IgG1 did not improve the diagnosis in this stage of disease.
Interestingly, the IgG2/PPA-ELISA allowed detecting the
majority of subclinically and clinically infected animals,
confirming our preliminary studies [13, 25].
Although sera were preadsorbed, three animals of the
healthy control group showed OD values higher than the cut-
off of the IgG2/PPA-ELISA (Figure 1 and Table 1). This could
be related to the lower specificity (92.1%).
Our study demonstrates that the IgG/PPA-ELISA is
the best to identify clinically infected animals, with high
sensitivity and specificity, in accordance with the accepted
statement that conventional ELISAs mostly identify this
category of infected cattle [21, 23].
On the other hand, our IgG2/PPA-ELISA improved the
number of subclinically infected cattle detected as compared
with conventional IgG/PPA-ELISA (53.8 versus 23.1%),
maintaining high levels of specificity. Nevertheless, this
sensitivity is slightly lower than that reported by Paolicchi
[33] using an IgG/PPA-ELISA, although this could be related
to the number of animals included (26 versus 8 animals).
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Table 2: Performances of isotypes/PPA-ELISAs for subclinically infected and clinically infected cattle.
Subclinically infected Clinically infected
PPA
AUCs Comparison of AUCs
PPA
AUCs Comparison of AUCs
ELISA ELISA
IgG 0.719 IgG ∼ IgG1 P = 0.0858 IgG 0.998 IgG ∼ IgG1 P = 0.0057
IgG1 0.526 IgG ∼ IgG2 P = 0.2402 IgG1 0.805 IgG ∼ IgG2 P = 0.0721
IgG2 0.812 IgG1 ∼ IgG2 P = 0.0048 IgG2 0.927 IgG1 ∼ IgG2 P = 0.0913
Estimated area under the curve (AUC) of each test and pairwise statistical analysis.




ELISA Subclinically Clinically Total
IgG 100.0% 23.1% 92.9% 47.5%
IgG1 94.7% 11.5% 57.1% 27.5%
IgG2 92.1% 53.8% 85.7% 65.0%
The specificity of isotypes/PPA-ELISAs was calculated as % of cattle from
the healthy control group testing negative. The sensitivity of each test was
estimated as % of infected cattle (subclinically infected, clinically infected,
or both) testing positive.
The sensitivity of fecal culture has been reported to be too
low to define absence of Map infection for animals residing in
known infected herds [21]. In fact, Map-infected cattle in the
early stage may shed bacteria under detectable levels using
current methods, including culture and PCR [35]. In the
same way, Nielsen [37] has recently highlighted the impor-
tance of the study of Map-infected shedder and nonshedder
animals to evaluate an immune-based diagnostic test. Thus,
in the present work, we incorporated a group of exposed
animals from Map-infected herds, excluding them from the
specificity and sensitivity analysis. In this group, the use of
IgG2/PPA-ELISA allowed detection of more positive animals
than the other isotypes evaluated (63.3 versus 26.7 or 3.3%).
Using a IgG/PPA-ELISA test, Huda et al. detected 11% of
exposed animals as positive [31].
New antigens have been proposed to increase the sen-
sitivity of JD diagnosis by IgG/ELISA [34, 36, 38]. Thus,
it could be interesting to evaluate those antigens in an
IgG2/ELISA.
In conclusion, our results show that IgG2/PPA-ELISA
improves detection of subclinically Map-infected cattle or
herds with animals in all stages of JD and in combination
with IgG/PPA-ELISA may improve differentiation of clinical
stages of disease. More studies should be conducted to
better approach the utility of the IgG2/PPA-ELISA, in
which, naturally and experimentally infected cattle should
be included and the infection status should be supported
by histopathological examination and culture of tissues. In
addition, the usefulness of IgG2 detection in serological tests
for Johne’s Disease diagnosis should be further evaluated.
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